Financials
Financial year 2025
Gross margin
€ -66
▼ 3% vs 2024
Profit
Caution€ -33,175
▼ 2672% vs 2024
Debts
Low€ 510
▲ 32% vs 2024
EPM Pharma Invest from Sint-Martens-Latem, company number BE0538590817, closed financial year 2025 with a result of € -33,175 after tax. For that financial year EPM Pharma Invest recorded a gross margin of € -66 and equity of € 109,705. Compared with financial year 2024, the result moved from € 1,290 to € -33,175. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
What happened at EPM Pharma Invest?
What happened at EPM Pharma Invest in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 33,175 (▼ 2672% vs 2024). Source: NBB ↗
- New establishment in Sint-Martens-Latem. KBO
- NESCH INVEST BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 37,973 loss in 2021 to € 33,175 loss in 2025.
Best year ever: 2024, with € 1,290 profit.
A new publication or filing at EPM Pharma Invest? We notify you, reason included.
Follow EPM Pharma InvestNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind EPM Pharma Invest is NESCH INVEST BV. NESCH INVEST BV is also behind MAB Consult Europe, RXW Group, PhiDeX Inc., PHIDEX CALN and Advantage Real Estate.
Directors
According to the 2025 annual accounts
Director · represented by Geert Van Gijseghem
Also active at: MAB Consult Europe, RXW Group, PhiDeX Inc. +6 more
since 2013
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 180 box 4 C
9830 Sint-Martens-Latem
Kortrijksesteenweg 180 box 4c
9830 Sint-Martens-Latem
Active since 13 September 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
ADMISOL
€ 1.6 million gross margin · 2025
MAB Consult Europe same network
€ -849 gross margin · 2025
CASA GRANDE
€ 373,195 gross margin · 2025
RXW Group same network
€ -140,092 gross margin · 2025
LES AMIS DE NORBERT
€ -9,140 gross margin · 2025
+11 more
Details
- Company number
- 0538.590.817
- VAT number
- BE 0538.590.817
- Registered office
- Kortrijksesteenweg 180 bus 4 C, 9830 Sint-Martens-Latem
- Names & denominations
- EPM Pharma Invest
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 September 2013
- Peppol
- Not registered